Reference Intervals in Coagulation Testing: Verification After a Method Change

A reference interval can look like a fixed line in a laboratory report, but it belongs to a specific testing system. Reagent composition, analyzer detection, incubation settings, specimen handling, population characteristics, and statistical method all influence the interval. When a laboratory changes a coagulation reagent, analyzer, application, or major pre-analytical process, simply copying the previous interval can create a quiet reporting error.

Verification does not always mean building a new interval from the beginning. The practical task is to determine whether an existing interval is suitable for the laboratory’s current method and population. If it is not, the laboratory may need a larger local study. The decision should be planned as part of implementation, not discovered after the new method has already entered routine use.

Identify what has actually changed

A change of analyzer may alter clot-detection technology, reaction volumes, temperature control, mixing, endpoint algorithms, or optical interference handling. A reagent change may alter thromboplastin source, phospholipid composition, activator, buffer, sensitivity, or lot behavior. Even when two products carry the same test name, their result distributions may not be interchangeable.

The laboratory should document the old and new systems in enough detail to understand the risk. For PT and APTT, this includes reagent and analyzer combinations, application settings, result units, lot numbers, sample preparation, and the population represented by the existing interval. For fibrinogen, thrombin time, D-Dimer, FDP, or antithrombin, calibration, measuring range, and reporting conventions may also be relevant.

Separate reference intervals from clinical decision limits

A reference interval describes results observed in a defined reference population under defined conditions. A clinical decision limit is selected for a diagnostic or management purpose and may come from clinical evidence, guidelines, or a validated algorithm. The two concepts are not interchangeable.

This distinction matters for coagulation reporting. APTT and PT commonly use local reference intervals, while D-Dimer workflows often use validated assay-specific thresholds rather than a conventional healthy-population interval. INR is a standardized calculation with its own requirements. Laboratories should label and manage each type of limit correctly instead of treating every number on the report as a reference range.

Review the proposed interval before collecting samples

An interval may come from a manufacturer’s study, a transfer from another site using the same system, published data, or the laboratory’s previous method. Before verification, the laboratory should review how the interval was established: population, sample size, exclusions, specimen type, collection conditions, analyzer, reagent, units, and statistical approach.

If the source system differs materially from the local system, a small verification exercise may give false confidence. The interval must also match the intended population. Adult intervals cannot automatically be applied to pediatric or pregnancy-related testing, and a site serving a specialized population may need additional consideration. Local regulatory and accreditation requirements should guide the final protocol.

Select reference individuals carefully

Verification samples should represent people expected to be free of conditions or exposures that affect the test. Selection criteria may consider medication, recent illness, pregnancy, liver disease, bleeding or thrombotic history, and other relevant factors. The process should protect privacy and follow local ethical and laboratory requirements.

Pre-analytical consistency is essential. Samples should use the correct citrate tube and fill, controlled collection, prompt mixing, suitable transport, validated centrifugation, and testing within the defined stability period. Poor sample quality widens the observed distribution and can make a suitable interval appear unsuitable.

Use a predefined verification rule

The laboratory should define the number of samples, allowable observations outside the proposed interval, and follow-up action before testing begins. A commonly used verification design evaluates a modest set of qualified reference samples and accepts the interval when only a limited number fall outside it. Exact criteria should follow the laboratory’s applicable standard and policy.

Results should be reviewed individually as well as statistically. An outlying result may reflect sample quality, an unrecognized exclusion factor, transcription, or analytical error. Repeating a sample simply because it falls outside the interval is not a neutral action; the reason for repeat testing must be defined. If the interval fails verification, the laboratory should not adjust the limits informally around the collected data.

Evaluate method comparison alongside the interval

Patient-sample comparison and reference-interval verification answer different questions. Comparison shows how the new system relates to the current system across patient results. Reference verification assesses whether the proposed limits fit the local reference population. A method can correlate well with the old system and still require different limits if it has systematic bias.

For PT and APTT, normal-range behavior deserves close attention because a small shift can change flagging near the interval boundary. Abnormal samples are still needed for broader method verification. For quantitative assays, the laboratory should also assess calibration, precision, linearity or measuring range, and relevant interference according to the implementation plan.

Configure and validate reporting

Once approved, the interval must be entered consistently in the analyzer, middleware, laboratory information system, printed reports, and procedure documents. Units, decimal places, age or sex partitions where used, and interpretive comments should be checked with test records. Staff should confirm that abnormal flags appear correctly at both limits.

The effective date and method association should be traceable. If two analyzers or reagent systems operate in parallel, reports must apply the correct interval to each result. A generic laboratory-wide interval can be unsafe when systems are not equivalent.

Plan periodic review and change control

Reference intervals should be reviewed when the method, reagent formulation, analyzer application, population, or specimen process changes materially. QC trends and patient-result distributions can provide signals, but they do not replace formal review. Lot changes usually require focused verification rather than a new reference interval, unless evidence suggests a meaningful shift.

Manufacturers and distributors support this process by supplying method-specific interval information, study design details, analyzer applications, lot-change guidance, and comparison data. For OEM and localization projects, reference-interval planning should be included in launch documentation and training. A credible implementation makes clear what evidence the supplier provides and what the local laboratory must verify.

Reference-interval verification is a small project with a large reporting consequence. By defining the system, selecting appropriate samples, using predetermined rules, and validating the reporting chain, laboratories can change methods without quietly carrying forward limits that no longer fit.